• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用患者来源的类器官对肿瘤异质性进行特征描述的深度学习模型。

A deep-learning model for characterizing tumor heterogeneity using patient-derived organoids.

机构信息

Research and Development, Advanced Core Technology Japan Unit 2, Evident Corp. Hachioji, 192-0033, Tokyo, Japan.

Translational Research Center, Fukushima Medical University, 960-1295, Fukushima, Japan.

出版信息

Sci Rep. 2024 Oct 1;14(1):22769. doi: 10.1038/s41598-024-73725-w.

DOI:10.1038/s41598-024-73725-w
PMID:39354045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11445485/
Abstract

Genotypic and phenotypic diversity, which generates heterogeneity during disease evolution, is common in cancer. The identification of features specific to each patient and tumor is central to the development of precision medicine and preclinical studies for cancer treatment. However, the complexity of the disease due to inter- and intratumor heterogeneity increases the difficulty of effective analysis. Here, we introduce a sequential deep learning model, preprocessing to organize the complexity due to heterogeneity, which contrasts with general approaches that apply a single model directly. We characterized morphological heterogeneity using microscopy images of patient-derived organoids (PDOs) and identified gene subsets relevant to distinguishing differences among original tumors. PDOs, which reflect the features of their origins, can be reproduced in large quantities and varieties, contributing to increasing the variation by enhancing their common characteristics, in contrast to those from different origins. This resulted in increased efficiency in the extraction of organoid morphological features sharing the same origin. Linking these tumor-specific morphological features to PDO gene expression data enables the extraction of genes strongly correlated with intertumor differences. The relevance of the selected genes was assessed, and the results suggest potential applications in preclinical studies and personalized clinical care.

摘要

肿瘤的遗传和表型多样性在疾病演变过程中产生异质性,这在癌症中很常见。鉴定每个患者和肿瘤特有的特征是精准医学和癌症治疗临床前研究的核心。然而,由于肿瘤内和肿瘤间的异质性增加了疾病的复杂性,这增加了有效分析的难度。在这里,我们介绍了一种顺序深度学习模型,预处理以组织由于异质性产生的复杂性,这与直接应用单一模型的一般方法形成对比。我们使用患者来源的类器官(PDO)的显微镜图像来描述形态异质性,并确定与区分原始肿瘤之间差异相关的基因子集。PDO 反映了它们起源的特征,可以大量和多样化地复制,通过增强它们的共同特征来增加变异,与来自不同起源的 PDO 相反。这提高了提取具有相同起源的类器官形态特征的效率。将这些肿瘤特异性形态特征与 PDO 基因表达数据联系起来,可以提取与肿瘤间差异强烈相关的基因。评估了所选基因的相关性,结果表明其在临床前研究和个性化临床护理中有潜在的应用。

相似文献

1
A deep-learning model for characterizing tumor heterogeneity using patient-derived organoids.利用患者来源的类器官对肿瘤异质性进行特征描述的深度学习模型。
Sci Rep. 2024 Oct 1;14(1):22769. doi: 10.1038/s41598-024-73725-w.
2
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.前列腺癌中的患者来源类器官:提高精准医学中的治疗效果。
Mol Cancer. 2021 Sep 29;20(1):125. doi: 10.1186/s12943-021-01426-3.
3
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.肿瘤患者源性类器官的转录组肿瘤内异质性可能反映起源肿瘤的独特生物学特征。
Breast Cancer Res. 2023 Feb 21;25(1):21. doi: 10.1186/s13058-023-01617-4.
4
Organoid technology in cancer precision medicine.类器官技术在癌症精准医学中的应用。
Cancer Lett. 2019 Aug 10;457:20-27. doi: 10.1016/j.canlet.2019.04.039. Epub 2019 May 9.
5
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.患者来源的类器官在人类癌症中的应用:基础研究和精准医学的平台。
Mol Biomed. 2024 Feb 12;5(1):6. doi: 10.1186/s43556-023-00165-9.
6
Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.从内镜活检和手术组织中开发患者来源的胃癌类器官。
Ann Surg Oncol. 2018 Sep;25(9):2767-2775. doi: 10.1245/s10434-018-6662-8. Epub 2018 Jul 12.
7
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.患者来源的类器官模型可模拟转移性胃肠道癌症的治疗反应。
Science. 2018 Feb 23;359(6378):920-926. doi: 10.1126/science.aao2774.
8
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.癌症类器官模型在药物筛选和个体化治疗中的应用。
Cells. 2019 May 17;8(5):470. doi: 10.3390/cells8050470.
9
Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.建立患者来源的类器官,以指导乳腺癌患者的个体化治疗。
Int J Cancer. 2024 Jul 15;155(2):324-338. doi: 10.1002/ijc.34931. Epub 2024 Mar 27.
10
Organoids: An intermediate modeling platform in precision oncology.类器官:精准肿瘤学中的中间建模平台。
Cancer Lett. 2018 Feb 1;414:174-180. doi: 10.1016/j.canlet.2017.11.021. Epub 2017 Nov 22.

引用本文的文献

1
Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck Cancer.整合人工智能驱动的数字病理学和基因组学,以建立患者来源的类器官作为头颈癌药物反应的新型替代模型。
bioRxiv. 2025 Jun 26:2025.06.24.660824. doi: 10.1101/2025.06.24.660824.
2
A computed tomography-based radiomics prediction model for BRAF mutation status in colorectal cancer.一种基于计算机断层扫描的结直肠癌BRAF突变状态的影像组学预测模型。
Abdom Radiol (NY). 2025 May 15. doi: 10.1007/s00261-025-04983-z.

本文引用的文献

1
OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics.OrganoID:一个用于追踪和分析单细胞动态的多功能深度学习平台。
PLoS Comput Biol. 2022 Nov 9;18(11):e1010584. doi: 10.1371/journal.pcbi.1010584. eCollection 2022 Nov.
2
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.免疫检查点阻断的反应、耐药和毒性的特征。
Cell. 2021 Oct 14;184(21):5309-5337. doi: 10.1016/j.cell.2021.09.020. Epub 2021 Oct 7.
3
A pan-cancer organoid platform for precision medicine.
泛癌症类器官平台用于精准医学。
Cell Rep. 2021 Jul 27;36(4):109429. doi: 10.1016/j.celrep.2021.109429.
4
Text Data Augmentation for Deep Learning.用于深度学习的文本数据增强
J Big Data. 2021;8(1):101. doi: 10.1186/s40537-021-00492-0. Epub 2021 Jul 19.
5
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids.基于患者来源肿瘤类器官的高通量体外检测方法。
J Vis Exp. 2021 Jun 14(172). doi: 10.3791/62668.
6
Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy.泛癌种中 HLA 基因表达与癌症预后和免疫治疗疗效的关联。
Br J Cancer. 2021 Aug;125(3):422-432. doi: 10.1038/s41416-021-01400-2. Epub 2021 May 12.
7
Construction of patient-derived tumor models to evaluate anticancer agents and cancer immunotherapy.构建患者来源的肿瘤模型以评估抗癌药物和癌症免疫疗法。
Oncol Lett. 2021 May;21(5):406. doi: 10.3892/ol.2021.12667. Epub 2021 Mar 22.
8
Deconstructing the sources of genotype-phenotype associations in humans.剖析人类基因型-表型关联的来源。
Science. 2019 Sep 27;365(6460):1396-1400. doi: 10.1126/science.aax3710.
9
OrgaQuant: Human Intestinal Organoid Localization and Quantification Using Deep Convolutional Neural Networks.OrgaQuant:使用深度卷积神经网络进行人体肠道类器官的定位和定量分析。
Sci Rep. 2019 Aug 28;9(1):12479. doi: 10.1038/s41598-019-48874-y.
10
Morphophenotypic classification of tumor organoids as an indicator of drug exposure and penetration potential.肿瘤类器官的形态表型分类作为药物暴露和渗透潜力的指标。
PLoS Comput Biol. 2019 Jul 16;15(7):e1007214. doi: 10.1371/journal.pcbi.1007214. eCollection 2019 Jul.